Abivax S.A.
Abivax S.A. (ABVX) Stock Overview
Explore Abivax S.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
8.5B
P/E Ratio
-35.92
EPS (TTM)
$-5.40
ROE
50.78%
ABVX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Abivax S.A. (ABVX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 64.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $136.52.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -35.92 and a market capitalization of 8.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.